Intervention
GM-CSF
ClinicalTrials.gov intervention label
Clinical trials
22 shownAutologous Stem Cell Transplantation in Patients With Systemic SclerosisNCT03630211 · 2018-07-31
RECRUITINGVinorelbine Metronomic Chemotherapy Combined With Hypofractionated Radiotherapy, PD-1/PD-L1 Sequential GM-CSF and IL-2 for Treatment of Advanced Refractory Non-small Cell Lung Cancer and Breast Cancer(PRaG 6.0)NCT05603013 · 2022-10-30
UNKNOWNIBI188 Combination Therapy in Solid TumorsNCT04861948 · 2021-05-25
TERMINATEDSBRT in Combination With Sintilimab and GM-CSF for the Treatment of Advanced NSCLCNCT04106180 · 2019-09-30
UNKNOWNGalinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced CancersNCT03761914 · 2019-09-30
COMPLETEDpTVG-HP and Nivolumab in Patients With Non-Metastatic PSA-Recurrent Prostate CancerNCT03600350 · 2018-09-10
ACTIVE_NOT_RECRUITINGFirst-time-in-Human (FTIH) Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single (in Both Fed and Fasted States) or Repeat Doses of GSK3358699NCT03426995 · 2018-03-13
TERMINATEDIpilimumab and GMCSF Immunotherapy for Prostate CancerNCT01530984 · 2015-06-01
WITHDRAWNPhase II Trial of Combination Immunotherapy With NeuVax and Trastuzumab in High-risk HER2+ Breast Cancer PatientsNCT02297698 · 2014-10-01
COMPLETEDCombination Vaccine Immunotherapy (DRibbles) for Patients With Definitively-Treated Stage III Non-small Cell Lung CancerNCT01909752 · 2013-07-01
COMPLETEDCombination Immunotherapy With Herceptin and the HER2 Vaccine NeuVaxNCT01570036 · 2013-05-21
COMPLETEDA Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate CancerNCT01322490 · 2011-11-28
COMPLETEDNovel Interventions in HIV-1 InfectionNCT01130376 · 2009-09-01
TERMINATEDSafety and Efficacy Study of GM-CSF, Thalidomide Plus Docetaxel in Prostate CancerNCT00450008 · 2006-12-01
TERMINATEDPhase II GM-CSF Plus Mitoxantrone in Hormone Refractory Prostate CancerNCT00477087 · 2006-07-01
TERMINATEDTrial of GM-CSF Given in Combination With Ketoconazole and Mitoxantrone in Patients With Progressive Prostate CancerNCT00447473 · 2006-07-01
TERMINATEDActivity of TroVax® Alone vs. TroVax® Plus GM-CSF in Patients With Prostate CancerNCT00448409 · 2006-05-01
COMPLETEDNeoadjuvant Treatment of Breast CancerNCT00254592 · 2005-10-01
COMPLETEDNeoadjuvant Biweekly Treatment Followed by Weekly Treatment of Breast CancerNCT00256243 · 2004-04-01
COMPLETEDSafety of and Immune Response to a New HIV Vaccine: HIV CTL MEPNCT00076037 · 2004-04-01
COMPLETEDHerceptin and GM-CSF for Metastatic Breast CancerNCT00429104 · 2002-08-01
COMPLETEDStudy of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) for Patients With Rising Prostate-Specific Antigen (PSA)NCT00678054 · 1999-04-01
COMPLETEDCommon conditions
Breast Cancer5Prostatic Neoplasms4Prostate Cancer3Carcinoma, Non-Small-Cell Lung2Acute Myelogenous Leukemia1Arthritis, Rheumatoid1Carcinoma Breast1Colorectal Cancer1Diffuse Sclerosis Systemic1HIV Infections1HIV-1 Infection1Interstitial Lung Disease1Lung Adenocarcinoma1NSCLC Stage IV1Osteosarcoma1Ovarian Cancer1Prostate Cancer Metastatic1Pulmonary Hypertension1Small-cell Lung Cancer1Solid Tumors1Systemic Sclerosis1Triple-negative Breast Cancer1
Leading sponsors
The Methodist Hospital Research Institute3Bavarian Nordic1Cancer Insight, LLC1Fudan University1George E. Peoples1GlaxoSmithKline1Imperial College London1Innovent Biologics (Suzhou) Co. Ltd.1Lawrence Fong1M.D. Anderson Cancer Center1National Institute of Allergy and Infectious Diseases (NIAID)1Paul Szabolcs1Rita Sanghvi, Mehta1Second Affiliated Hospital of Soochow University1Sellas Life Sciences Group1
Trial status mix
COMPLETED11
TERMINATED6
UNKNOWN2
ACTIVE_NOT_RECRUITING1
RECRUITING1
WITHDRAWN1
Phase mix
PHASE217
PHASE15
PHASE31
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.